When will Beam Therapeutics submit a BLA for Risto-cel?
6.0 pts (24h)Health & MedicineOne-OffCiencia1m
KalshiComprobar disponibilidadKYC requerido2% de comisiónDatos de resolución verificadosCalibración aceptableProbabilidad implícita actual
before April 2027 93%Líder entre 6 opciones
Calidad del mercado
46 / 100
Baja calidadVolumen 24h
17,2 €
Liquidez
16 mil €
Liquidez mediaSpread
6.0 pt
Spread amplioDatos de mercado
Actualizado hace 7 minutos
24 mar 26, 14:00 UTC1 nov 26, 5:00 UTC
Tendencias
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
KalshiFDA decision: Ivonescimab by Summit Therapeutics (in 2026)
KalshiWhen will Compass Pathways submit a NDA for COMP360 psilocybin?
KalshiDid COVID-19 come from a laboratory?
Manifold MarketsWill we get AGI before 2028?
Manifold MarketsWill aging be solved by EOY 2035?
Manifold MarketsReglas
If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Sep 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Oct 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Nov 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Dec 1, 2026, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Jan 1, 2027, then the market resolves to Yes.
- If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Apr 1, 2027, then the market resolves to Yes.
Mercados abiertos
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.2pt97%
- Yes+0.2pt3%
- Volumen total
- 15,6 M €
- Volumen 24h
- 30,4 mil €
POLYMARKETEbola pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volumen total
- 652,8 mil €
- Volumen 24h
- 3,5 mil €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes-0.7pt3%
- Volumen total
- 1,6 M €
- Volumen 24h
- 2,9 mil €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000+1.0pt97%
- Above 600059%
+2 resultados más
- Volumen total
- 865,3 mil €
- Volumen 24h
- 2,7 mil €
POLYMARKETNew pandemic in 2026?
- No+1.0pt94.1%
- Yes-1.0pt5.9%
- Volumen total
- 915,3 mil €
- Volumen 24h
- 1,4 mil €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+1.0pt65%
- September41%
- June28%
- Volumen total
- 84 mil €
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Will 3 mg THC beverages be federally legal to sell?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve CagriSema?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)
Preguntas frecuentes
- ¿Cuáles son las probabilidades actuales de When will Beam Therapeutics submit a BLA for Risto-cel??
- Kalshi cotiza before April 2027 al 93% a fecha de 9 de septiembre de 2026.
- ¿Cuándo se resuelve When will Beam Therapeutics submit a BLA for Risto-cel??
- Está previsto que When will Beam Therapeutics submit a BLA for Risto-cel? se resuelva el 1 de noviembre de 2026.
- ¿Cómo se liquida When will Beam Therapeutics submit a BLA for Risto-cel??
- Kalshi liquida este mercado del siguiente modo: If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Sep 1, 2026, then the market resolves to Yes.